Nirgundi Taila: Benefits, Evidence, Dosage & Safety
TL;DR
Nirgundi taila is a classical Ayurvedic medicated oil from Vitex negundo (nirgundi) leaves, used externally for joint pain, swelling, and stiffness. One small open-label trial (21 osteoarthritis patients, 60 days) reported improvement, but it had no control group. Leaf extracts show anti-inflammatory effects in animal models; evidence for the oil itself remains thin.
(Sources: Journal of Research in Traditional Medicine; Shinde et al., Planta Medica, 2010.)
What it is
Nirgundi taila is a medicated oil (taila) prepared by processing the leaves of nirgundi: Vitex negundo L. (family Lamiaceae, formerly Verbenaceae), a large aromatic shrub found across India: in a base oil, classically sesame oil (tila taila). The Ayurvedic Pharmacopoeia of India (Government of India) includes a monograph for the nirgundi leaf defining its identity and quality standards. As a taila, it is meant for external application: massage or topical application over affected joints, sometimes with gentle warming.
Traditional use
Nirgundi is one of Ayurveda's classic herbs for vata disorders. Classical texts describe it as vata-kapha-shamaka (pacifying vata and kapha), with shothahara (swelling-reducing) and vedanasthapana (pain-relieving) action, and its leaves are traditionally used externally, as warm poultices, fomentation, or medicated oil, for joint pain, sprains, swellings, and stiffness (JRTM clinical trial background; Shinde et al., Planta Medica, 2010). These are traditional claims; the small amount of modern evidence is assessed below.
What modern research says
Osteoarthritis (Sandhigatavata) — one small open-label trial
The most directly relevant study is an open-label, single-arm clinical trial in which 21 patients aged 40–80 with osteoarthritis (sandhigatavata) applied nirgundi taila externally to affected joints for 20 minutes twice daily for 60 days. The authors reported symptomatic improvement in joint pain, swelling, range of movement, and walking/climbing ability, concluding the oil gave "mild improvement in maximum subjects" (Journal of Research in Traditional Medicine). This is encouraging but weak evidence: single-arm means there was no control or placebo group, so natural improvement or expectation effects cannot be ruled out, and 21 patients is a small sample.
Anti-arthritic effects in animal models
In a 2010 study published in Planta Medica, a methanol extract of Vitex negundo leaves (standardized for vitexin and negundoside) at 100 and 200 mg/kg significantly inhibited carrageenan-induced paw edema and reduced paw swelling and arthritis scores in the complete Freund's adjuvant arthritis model in rats (Shinde et al., Planta Medica, 2010). A separate animal study found that a standardized seed extract reduced paw edema and arthritis scores in adjuvant-induced arthritis in rats (Zheng et al.). Animal-model results are a starting point, not proof that the oil relieves human joint pain.
Anti-inflammatory mechanisms
Review literature notes that V. negundo contains flavonoids, iridoid glycosides (including negundoside), and terpenoids, and that preclinical studies describe modulation of inflammatory pathways such as NF-κB and pro-inflammatory cytokines (TNF-α, IL-6, IL-1β): consistent with, but not proof of, the traditional anti-inflammatory reputation (V. negundo in rheumatoid arthritis, Int. J. Drug Delivery Technology, 2024).
What the evidence does not support
There are no randomized, placebo-controlled trials of nirgundi taila itself, no studies comparing it with standard topical NSAIDs, and no data on long-term use or disease modification in arthritis. Claims that the oil "cures" arthritis or repairs cartilage are ahead of the data.
Dosage
There is no pharmacopoeial dosage for nirgundi taila. The only published clinical protocol is the one used in the open-label osteoarthritis trial: external application to the affected joint(s) for about 20 minutes, twice daily, for 60 days (Journal of Research in Traditional Medicine). This is a description of what was studied, not a recommendation, and the trial did not establish an optimal dose, frequency, or duration.
Safety & contraindications
Human safety data for nirgundi taila are limited. As an external oil it avoids the systemic exposure of oral medicines, but no large safety studies exist. A prudent approach: patch-test on a small area first if you have sensitive skin or eczema, avoid application on broken or infected skin, and do not use it as a substitute for evaluated treatment of inflammatory joint disease. Safety in pregnancy and breastfeeding has not been studied: consult a clinician.
FAQs
What is nirgundi taila used for?
It is a classical Ayurvedic medicated oil made from Vitex negundo (nirgundi) leaves, traditionally applied externally for joint pain, swelling, stiffness, and sprains (Journal of Research in Traditional Medicine). The modern evidence is limited to one small open-label trial and animal studies.
Does nirgundi taila work for knee osteoarthritis?
Possibly, mildly. In a 60-day open-label trial of 21 patients, twice-daily application improved pain, swelling, and mobility, but there was no control group and the authors themselves described the effect as mild (Journal of Research in Traditional Medicine). It is not proven to match or replace standard treatments.
Is nirgundi taila better than diclofenac gel?
There is no published head-to-head trial comparing nirgundi taila with diclofenac gel or other standard topical NSAIDs. Do not assume equivalence: the evidence base is far thinner.
How is nirgundi taila applied?
In the published trial, it was applied externally to the affected joint for about 20 minutes, twice daily, for 60 days (Journal of Research in Traditional Medicine). Traditional practice uses gentle massage, sometimes with the oil slightly warmed.
Is nirgundi taila safe in pregnancy?
There are no studies on its safety in pregnancy or breastfeeding. As with most medicated Ayurvedic oils, use in pregnancy should only follow advice from a qualified practitioner.
Can I take nirgundi internally instead?
This article is about the external oil. Oral Vitex negundo preparations are a different intervention with a different evidence and safety profile: do not extrapolate.
Sources
- "Efficacy of Nirgundi Taila application in the management of Sandhigatavata (Osteoarthritis) — an open labelled single arm clinical trial." Journal of Research in Traditional Medicine. — mail.bibliomed.org
- Shinde K et al. "Antiarthritic activity of Vitex negundo Linn." Planta Medica. 2010;76:P77. — thieme-connect.com
- Zheng et al. "Therapeutic effects of standardized Vitex negundo seeds extract on complete Freund's adjuvant induced arthritis in rats." — DOI · 10.1016/j.phymed.2014.02.003
- "*Vitex negundo* in rheumatoid arthritis: phytochemistry and mechanisms." Int J Drug Deliv Technol. 2024;15(4).
Related herbs
Disclaimer
This article is for educational purposes only and is not medical advice. The evidence for nirgundi taila consists of one small open-label trial and animal studies — it is not proven to treat or cure arthritis. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.